Peroxisomal Localization of a Truncated HMG-CoA Reductase under Low Cholesterol Conditions

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Biology

Background:

• 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) is a key enzyme in cholesterol biosynthesis, primarily located in the endoplasmic reticulum (ER).
• Previous studies have occasionally suggested HMGCR presence in peroxisomes, but its precise localization and regulation remain incompletely understood.

Purpose of the Study:

• To investigate the dual localization of HMGCR in the ER and peroxisomes.
• To elucidate the mechanism and conditions governing HMGCR peroxisomal import.

Main Methods:

• Co-immunofluorescence microscopy in human cell lines (THP-1, macrophages, fibroblasts).
• Density gradient centrifugation and Western blot analysis.
• Reporter assays to test peroxisomal targeting signal (PTS2) functionality.

Main Results:

• HMGCR exhibits dual localization in ER and peroxisomes in human cells under low cholesterol and statin treatment.
• A 76 kDa truncated HMGCR variant is found in peroxisomes, while full-length 96 kDa HMGCR is in the ER.
• Peroxisomal HMGCR import depends on PEX7 and a functional PTS2-like motif in the truncated variant, suggesting proteolytic processing and import.

Conclusions:

• HMGCR displays dual localization in ER and peroxisomes under specific cellular conditions (lipid depletion, statin treatment).
• A novel PTS2/PEX7-dependent pathway facilitates the import of a processed HMGCR fragment into peroxisomes.
• This finding contributes to understanding the complex regulation of HMGCR and cholesterol biosynthesis.